AKUMS DRUGS & PHARMACEUTICALS
Back to Cashflow Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹73 Cr | ₹-108 Cr | ₹125 Cr | ₹236 Cr | ₹-95 Cr |
What is the latest Cash Flow from Financing Activities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹-108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹236 Cr |
| Mar2021 | ₹-95 Cr |
How is Cash Flow from Financing Activities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹73 Cr | Positive | |
| Mar2024 | ₹-108 Cr | Negative | |
| Mar2023 | ₹125 Cr | -47.24 | |
| Mar2022 | ₹236 Cr | Positive | |
| Mar2021 | ₹-95 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,592.2 Cr | -8.4% | 3.1% | -8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | -8.4% |
3.1% |
-8.9% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses